Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box protein 27 (FBXO27) is a member of the F-box protein family, characterized by the presence of an approximately 40-amino acid F-box motif that mediates interaction with SKP1 in the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex[2][3][4]. As a substrate-recognition component of the SCF complex, FBXO27 recognizes both high-mannose and complex-type N-glycans on denatured or exposed glycoproteins—specifically those normally sequestered in the lumenal surface of lysosomes and other endomembrane structures[1]. Upon lysosomal damage, cytosolic FBXO27 binds to these exposed glycoproteins and promotes their K48-linked ubiquitination, notably targeting proteins such as LAMP2 and VAMP3/7, thereby accelerating the recruitment of autophagy machinery for clearance of damaged organelles (lysophagy)[1]. FBXO27 is unique among glycoprotein-binding F-box proteins in being N-myristoylated, allowing membrane targeting and efficient recruitment to damaged organelles[1]. While general roles for F-box proteins in cancer are recognized (either as tumor suppressors or oncogenes depending on the context), specific roles for FBXO27 in human diseases remain to be fully clarified[5]. No drugs are currently known to interact directly with FBXO27, and it is not yet considered a therapeutic target.
Not applicable; no current drugs known to target FBXO27 directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box protein 27 (FBXO27).